Inhibition of ligand‐independent constitutive activation of the Met oncogenic receptor by the engineered chemically‐modified antibody DN30

由 Vigna, Elisa, Chiriaco, Cristina, Cignetto, Simona, Fontani, Lara, Basilico, Cristina, Petronzelli, Fiorella, Comoglio, Paolo M.
發表在 Mol Oncol (2015)

Dual Constant Domain‐Fab: A novel strategy to improve half‐life and potency of a Met therapeutic antibody

由 Cignetto, Simona, Modica, Chiara, Chiriaco, Cristina, Fontani, Lara, Milla, Paola, Michieli, Paolo, Comoglio, Paolo M., Vigna, Elisa
發表在 Mol Oncol (2016)